Cancer Biology & Genetics Program

The Kathryn Taylor Lab

Research

Kathryn Taylor
Kathryn Taylor, PhD


Assistant Professor

Our laboratory studies neuron-cancer interactions, with a focus on developmental malignancies. Using a multi-disciplinary approach within the emerging field of cancer neuroscience, we leverage neuroscience tools and techniques to interrogate the microenvironmental influence of neural circuitry on pediatric and young adult cancers. Our mission is to identify key mechanisms that drive cancer progression and identify neuromodulatory approaches for rapid clinical translation.

Publications Highlights

K.R. Taylor, T. Barron, A. Hui, A. Spitzer, B. Yalçin, A.E. Ivec, A.C. Geraghty, G.H. Hartmann, M. Artz, S.M. Gillespie, Y.S. Kim, S. M. Jahan, H. Zhang, K. Shamardani, M. Su, L. Ni, P.P. Du, P.J. Woo, A. Silva-Torres, H.S. Venkatesh, R. Mancusi, A. Ponnuswami, S. Mulinyawe, M.B. Keough, I. Chau, R. Aziz-Bose, I. Tirosh, M.L. Suvà and M. Monje. “Glioma synapses recruit mechanisms of adaptive plasticity”. Nature. 2023; 623(7986):366-374.

K. R. Taylor and M. Monje. “Neuron-oligodendroglial interactions in health and malignant disease”. Nature Reviews Neuroscience. 2023; 24(12):733-746.

View All Publications

People

Kathryn Taylor

Kathryn Taylor, PhD



Assistant Professor

  • The Taylor laboratory studies the influence of the nervous system on pediatric and young adult cancers.
  • PhD, University of London, The Institute of Cancer Research
[email protected]
Email Address
646-888-2375
Office Phone

Achievements

  • Damon Runyon-Sohn Pediatric Cancer Fellowship (2017-2021)
  • Children’s Health Research Institute Fellowship
  • 2014 World Federation of Neuro-oncology and Society of Neuro-oncology (WNFO/ SNO) pediatric basic science award (supported by the Pediatric Brain Tumour Foundation).
  • Demonstrated how pediatric glioma synapses leverage mechanisms of adaptive plasticity, which in the healthy brain are known to regulate cognition.
  • Identified a novel cancer oncogene, ACVR1, in diffuse intrinsic pontine glioma.

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Kathryn Taylor discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2025 through disclosure submission in spring 2026). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures